-
He later became a neuroscientist, now at the Massachusetts Institute of Technology, spending most of his career doing basic research on how the brain's cells form connections during learning.
FORBES: Magazine Article
-
The outcome of meeting may have a big political impact inside the FDA. Many industry-watchers are seeing this as a tug-of-war between the career FDA employees who run the drug research division, who have kept Avandia on the market so far, and the the Obama appointees who currently run the agency.
FORBES: Three Things To Remember During The Avandia Panel
-
This ten year contraction has been forcing our highly skilled researchers to spend more time raising money than doing the research they spent decades training for, is encouraging established researchers to leave our shores in search of greater funding opportunities or to leave research altogether, and is discouraging the younger generation from embarking on a career in science.
FORBES: Legendary Drug Industry Executives Warn U.S. Science Cuts Endanger The Future